Arbutus Biopharma Corporation (NASDAQ:ABUS) Signals Intraday Volatility - Up $0.98

At present, the stock is 10.17% separated from the 52 week high and 176.60% from the low. About 2 shares traded. Victory Capital Management Inc. owned about 0.24% of Arbutus Biopharma Corporation as of its most recent filing with the Securities and Exchange Commission (SEC).

Arbutus Biopharma Corporation (NASDAQ:ABUS) shares have been labeled a top pick by Beta Research as it meets the A+ criteria outlined by the firm. The SI to Arbutus Biopharma Corporation's float is 1.2%.

The stock decreased 1.77% or $0.1 during the last trading session, reaching $5.55.

Arbutus Biopharma Corp (NASDAQ:ABUS) was the target of a large decline in short interest in the month of August. It has underperformed by 19.01% the S&P500.

About Arbutus Biopharma Corp Arbutus Biopharma Corporation, formerly Tekmira Pharmaceuticals Corporation, is a therapeutic solutions company. The company has market cap of $310.90 million. The Company is engaged in discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B infection (HBV), a disease of the liver caused by the hepatitis B virus (HBV). It now has negative earnings. It is developing a pipeline focused on advancing Ribo Nucleic Acid interference therapeutics (RNAi) using its Lipid Nanoparticle technology. It fall, as 62 investors sold BAC shares while 560 reduced holdings. Therefore 80% are positive.

On average, analysts expect that Arbutus Biopharma Corp will report full-year sales of $7.5 million for the current financial year, with estimates ranging from $2 million to $7.5 million. They issued a "buy" rating and a $32.00 price objective for the company.

Taking a closer look into the volatility on shares of Arbutus Biopharma Corporation (NASDAQ:ABUS), we notice that the stock is 46.60% off of the 20-Day Simple Moving Average. The firm has "Sell" rating given on Friday, July 8 by Chardan Capital Markets. Arbutus Biopharma Corp presently has a consensus rating of "Buy" and an average price target of $12.81. The stock's market capitalization is 305.39M. As per Friday, August 7, the company rating was initiated by Wedbush.

08/05/2016 - Arbutus Biopharma Corporation was downgraded to "market perform" by analysts at Leerink Swann.

More notable recent Arbutus Biopharma Corp (NASDAQ:ABUS) news were published by: which released: "Trading Arbutus Ahead Of Hepatitis B Data" on August 22, 2017, also with their article: "Company Spotlight: Arbutus Biopharma" published on September 15, 2017, published: "Arbutus Biopharma: 2 Ways For Shareholders To Win" on April 05, 2017.

The majority of analysts covering the equity have either a Buy or Strong Buy recommendation on the stock, yielding a consensus score of 2.00. The monthly stock performance comes in at 54.17%. Its down 0.01, from 0.91 in 2016Q3. Short shares fell from 550,388 to 418,041 over that period. 141 funds opened positions while 361 raised stakes. Partner Invest Mngmt Lp accumulated 9,875 shares.

As of the end of the quarter Sabby Management, LLC had sold a total of 399,600 shares trimming its position 61.6%. Holt Capital Advsr Ltd Dba Holt Capital Ptnrs Ltd Partnership invested 0.09% of its portfolio in U.S. Bancorp (NYSE:USB). The firm acquired 132,810 shares of the biopharmaceutical company's stock, valued at approximately $478,000. The Average True Range (ATR) is a measure of stock volatility. Rand Wealth Llc has 206,893 shares for 0.58% of their portfolio. Ubs Group Ag now holds 115 shares with a value of $0. Murphy Pohlad Asset Management Ltd Limited Liability Company holds 7,352 shares or 0.27% of its portfolio.

Like this


21 September 2017
Haley: Diplomacy efforts with North Korea 'pretty much exhausted'
Trump's earlier warning he would rain "fire and fury" on a recalcitrant North Korea, she said, was "not an empty threat". Trump plans to meet with Prime Minister Shinzo Abe and South Korean President Moon Jae-in on the sidelines of the U.N.

21 September 2017
Mattis: Diplomacy still leads in effort to denuclearize N. Korea
Mattis said the United States and Japan did not shoot it down because it did not pose a direct threat to either nation. North Korea has said it needs the capability to strike the US with a nuclear weapon to deter an American invasion.

21 September 2017
Hillary Clinton Blasts Trump's 'Very Dark, Dangerous' UN Speech on North Korea
Colbert ended the segment with two glasses of chardonnay, which Clinton said helped her recover from her November 8 letdown. But she warned that Russian Federation would continue to try to influence American democracy.

21 September 2017
Research Report For Sibanye Gold Limited (SBGL)
Here we'll take a quick glance at how the stock price is now trading in relation to some of its simple moving averages . The rating scale runs from 1 to 5 with 5 indicating a Strong Sell, 1 indicating a Strong Buy and 3 indicating a Hold.

21 September 2017
Tillerson calls for more limits on Iran's nuclear program
During an interview with Fox News, US Secretary of State Rex Tillerson said that Washington is interested in changing the Iranian nuclear deal.

21 September 2017
Gal Gadot's Wonder Woman will appear in 'Flashpoint'
Flashpoint is expected to come out sometime in 2020, but we can check out all the characters in Justice League on November 17. Gal Gadot probably won't mind being known as Wonder Woman for the rest of her life, but she's still going to branch out.

21 September 2017
Mexico City natural disaster : Force India driver Sergio Perez donates to fund
A powerful 7.1 quake hit Puebla on Tuesday with the tremors felt 76 miles away in Mexico City, killing over 200 people as buildings were toppled.

21 September 2017
Capital Fund Management SA Decreases Stake in Boston Properties, Inc. (NYSE:BXP)
Boston Properties (NYSE:BXP) last announced its quarterly earnings results on Tuesday, January 31st. (NYSE:BXP) for 16,038 shares. Jane Street Group LLC acquired a new stake in shares of Boston Properties in the first quarter valued at approximately $200,000.

21 September 2017
Rowan Companies plc (RDC) — Recommendation Trends Analysis
American Century Companies Inc. owned about 0.27% of Rowan Companies PLC worth $3,503,000 at the end of the most recent quarter. Robbins increased its stake in Rowan Companies Plc (RDC ) by 5.5% based on its latest 2016Q4 regulatory filing with the SEC.

21 September 2017
IBM Retirement Fund Buys 11391 Shares of Colgate-Palmolive Company (CL)
Over a month, it has seen its stock price volatility to stay at 6.02% while shortening the period to a week, volatility was 5.83%. It is positive, as 53 investors sold CL shares while 472 reduced holdings. 91 funds opened positions while 363 raised stakes.